Back to search

University of Leeds

Identification of novel inhibitors of the Co-Chaperone HOP in the context of KSHV infection

Abstract

dc:description.abstract

Molecular chaperones are an evolutionarily conserved family of proteins found across the five kingdoms of life. Molecular chaperone function is essential for maintenance of the proteome, ensuring proteins and protein complexes adopt the correct folding and conformational states. Kaposi’s sarcoma-associated herpesvirus (KSHV), like many other viruses, utilise host cell molecular chaperones, in particular the heat shock protein (HSP) machinery, enhancing both its latent and lytic replication cycles. Therefore, targeting HSPs may be an attractive antiviral therapeutic strategy. This is supported by findings that show HSP70 and HSP90 specific ATPase inhibitors result in effective inhibition of the KSHV lytic replication cycle. However, utilisation of these HSP inhibitors is not a clinically viable approach, due to redundancy in the HSP network and toxic side effects. Thus, alternative approaches to modulating the HSP70 and HSP90 system is an active area of research for pharmaceutical development. This thesis describes an alternative approach to inhibiting the host cell HSP machinery, by targeting the molecular co-chaperone HOP, which facilitates the transfer of client proteins from HSP70 to HSP90. The first aim was to determine whether HOP was essential for KSHV lytic replication and a viable therapeutic target. Results in chapter 3 show that HOP is redistributed to the nucleus during KSHV lytic replication with a proportion of HOP localising to KSHV replication and transcription complexes (vRTCs). Moreover, depletion studies show HOP is essential for efficient viral protein expression and infectious virion production. The second aim was to develop and validate a high-throughput fluorescent polarisation assay to screen potential inhibitors of HOP-HSP PPIs. Whilst no positive hit compounds were detected, assay efficacy and effectiveness were demonstrated. Therefore, in chapter 5 alternative approaches to develop HOP-HSP70 PPI inhibitors were investigated, including selective functional group and fragment screening, as well as peptide SAR development. Results provided some interesting findings to be taken forward in the development of early SAR relating to carboxylic acids. Moreover, peptide SAR identified a tryptophan containing peptide with enhanced activity. In conclusion, this work demonstrated that HOP is intrinsically involved in KSHV lytic replication and may provide future pharmaceutical opportunities. However, targeting HOP HSP interactions is a challenging medicinal chemistry problem.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Weaver, Frederick John
Advisors dc:contributor.advisor
  • Whitehouse, Adrian
  • Foster, Richard

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
95519952

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Weaver, Frederick John. Identification of novel inhibitors of the Co-Chaperone HOP in the context of KSHV infection. doctoral thesis, University of Leeds, 2023.